Covered recipient · General Payments record
MATTHEW F BOUCHONVILLE
Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism
General Payments · PY2018–2024
$6,055.57
- Reported across 116 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,288.11 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Insulet Corporation | $495.01 | 6 |
| PFIZER INC. | $305.83 | 4 |
| Novo Nordisk AS | $221.23 | 3 |
| BETA BIONICS, INC. | $142.35 | 1 |
| Tandem Diabetes Care, Inc. | $93.11 | 1 |
| Lilly USA, LLC | $17.26 | 1 |
| DEXCOM, INC. | $13.32 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| BETA BIONICS, INC. | $142.35 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087884275 | CMS |
| Dexcom, Inc. | $13.32 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154764438 | CMS |
| Insulet Corporation | $86.79 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116806380 | CMS |
| Insulet Corporation | $16.34 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116804542 | CMS |
| Insulet Corporation | $120.50 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116804538 | CMS |
| Insulet Corporation | $125.00 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116804536 | CMS |
| Insulet Corporation | $24.17 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116811575 | CMS |
| Insulet Corporation | $122.21 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116826074 | CMS |
| Lilly USA, LLC | $17.26 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135170176 | CMS |
| Novo Nordisk Inc | $12.86 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097802020 | CMS |
| Novo Nordisk Inc | $116.02 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096726536 | CMS |
| Novo Nordisk Inc | $92.35 | 06/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097345291 | CMS |
| PFIZER INC. | $91.05 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131718046 | CMS |
| PFIZER INC. | $79.63 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131713535 | CMS |
| PFIZER INC. | $43.91 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131712862 | CMS |
| PFIZER INC. | $91.24 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131741862 | CMS |
| Tandem Diabetes Care, Inc. | $93.11 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138745069 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.